Destiny Pharma
Stock Forecast, Prediction & Price Target
Destiny Pharma Financial Estimates
Destiny Pharma Revenue Estimates
Destiny Pharma EBITDA Estimates
Destiny Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| £135.02K N/A | £154.49K 14.41% | £831.55K 438.22% | Avg: £1.39M Low: £1.39M High: £1.39M avg. 68.01% | Avg: £1.81M Low: £1.81M High: £1.81M avg. 29.62% | Avg: £3.77M Low: £3.77M High: £3.77M avg. 108.16% | Avg: £3.04M Low: £3.04M High: £3.04M avg. -19.28% |
Net Income
% change YoY
| £-5.33M N/A | £-6.50M -21.80% | £-5.65M 13.01% | Avg: £-8M Low: £-7.70M High: £-7.70M avg. -41.41% | Avg: £-14.5M Low: £-13.91M High: £-13.91M avg. -81.25% | Avg: £-9.06M Low: £-9.06M High: £-9.06M avg. 37.46% | Avg: £-9.06M Low: £-9.06M High: £-9.06M avg. 0% |
EBITDA
% change YoY
| £-6.42M N/A | £-7.87M -22.62% | £-6.56M 16.63% | Avg: £-1.39M Low: £-1.39M High: £-1.39M avg. 78.71% | Avg: £-1.81M Low: £-1.81M High: £-1.81M avg. -29.62% | Avg: £-3.77M Low: £-3.77M High: £-3.77M avg. -108.16% | Avg: £-3.04M Low: £-3.04M High: £-3.04M avg. 19.28% |
EPS
% change YoY
| -$0.09 N/A | -$0.09 -3.81% | -$0.06 32.61% | Avg: -$0.09 Low: -$0.09 High: -$0.09 avg. -36.21% | Avg: -$0.15 Low: -$0.15 High: -$0.15 avg. -80.58% | Avg: -$0.1 Low: -$0.1 High: -$0.1 avg. 34.85% | Avg: -$0.1 Low: -$0.1 High: -$0.1 avg. 0% |
Operating Expenses
% change YoY
| £6.42M N/A | £7.87M 22.62% | £7.39M -6.07% | Avg: £95.68M Low: £95.68M High: £95.68M avg. 1193.91% | Avg: £124.03M Low: £124.03M High: £124.03M avg. 29.62% | Avg: £258.19M Low: £258.19M High: £258.19M avg. 108.16% | Avg: £208.40M Low: £208.40M High: £208.40M avg. -19.28% |
FAQ
What is Destiny Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -21.29% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -7.70M, average is -8M and high is -7.70M.
What is Destiny Pharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 46.63% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is £1.39M, average is £1.39M and high is £1.39M.
What is Destiny Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -20.48% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.09, average is -$0.09 and high is £-0.08.